RVLP - RVL Pharmaceuticals plc (RVLP) CEO Brian Markison on Q4 2021 Results - Earnings Call Transcript

RVL Pharmaceuticals plc (RVLP) Q4 2021 Earnings Conference Call March 30, 2022, 4:30 PM ET Company Participants Brian Markison – Chief Executive Officer Andrew Einhorn – Chief Financial Officer JD Schaub – Chief Operating Officer Lisa Wilson – Investor Relations Conference Call Participants Louise Chen – Cantor Fitzgerald Douglas Tsao – H.C Wainwright Greg Fraser – Truist Securities Presentation Operator Good day and thank you for standing by and welcome to the RVL Pharmaceuticals, Fourth Quarter 2021 Earnings Results and Business Update Call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions] I will now return the conference over to who's speaking today, Lisa Wilson, Investor Relations for RVL. Please go ahead. Lisa Wilson Thank you, Operator. Welcome to RVL Pharmaceuticals, Fourth Quarter 2021 business update call. This is Lisa Wilson, Investor Relations for RVL. With me

For further details see:

RVL Pharmaceuticals plc (RVLP) CEO Brian Markison on Q4 2021 Results - Earnings Call Transcript